Ash Access Technology, Inc. is a privately
held company dedicated to advancing the care of patients requiring
vascular access and infection control in both the acute and chronic health care environments.
Our core technologies are specifically targeting the primary complications
a patient on vascular access likely will experience - a rapidly escalating
incidence of deadly infections (CRBSI) and poor patency (blood flow
you are a current shareholder of Ash Access Technology Inc. you
may view additional corporate updates and information. (Temporarily disabled.)